AzurRx BioPharma

$0.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.001 (+0.13%) Today

+$0.0189 (+2.42%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AZRX and other stocks, options, and ETFs commission-free!

About AZRX

AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It focuses on MS1819-SD, and B-Lactamase program products. The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY. The listed name for AZRX is AzurRx BioPharma, Inc. Common Stock.

CEO

James E. Sapirstein, MBA

Employees

Headquarters

Brooklyn, New York

Founded

2014

Market Cap

22.56M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

178.21K

High Today

$0.80

Low Today

$0.78

Open Price

$0.80

Volume

82.82K

52 Week High

$1.94

52 Week Low

$0.3709

Collections

Technology

Health

Biotechnology

Research And Development

2016 IPO

North America

AZRX Earnings

-$0.46

-$0.31

-$0.15

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Estimated

— per share

Actual

-$0.46 per share